- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
What's Behind the Volpara-ScreenPoint Partnership?
Volpara Solutions Chief Knowledge Officer Julian Marshall talks with Diagnostic Imaging about the impetus and impact of the partnership with ScreenPoint Medical
During the Radiological Society of North America 2019 annual meeting Diagnostic Imaging sat down with Julian Marshall, chief knowledge officer for breast imaging analytics company Volpara Solutions, to discuss the growing partnership with image analysis developer ScreenPoint Medical. This partnership brings ScreenPoint's artificial intelligence-based detection and decision support software to Volpara customers.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
